Beth Karlan, MD

Cedars-Sinai, UCLA

KarlanDr. Karlan is Director of the Cedars-Sinai Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Director of the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology and Director of the Gilda Radner Hereditary Cancer Program. She holds the Board of Governors Chair in Gynecologic Oncology. Dr. Karlan is also Professor of Obstetrics and Gynecology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Board certified in Obstetrics and Gynecology and in Gynecologic Oncology, Dr. Karlan has been awarded research grants from the Department of Defense, National Institutes of Health and the American Cancer Society. Her research interests include the genetic definition and phenotypic determinants of human ovarian carcinomas, molecular biomarker discovery and inherited cancer susceptibility. Dr. Karlan has written over 200 peer reviewed articles, and is Editor-in-Chief of the publications Gynecologic Oncology and Gynecologic Oncology Case Reports.

Dr. Karlan served as President of SGO in 2005-2006 and has held leadership positions with the Gynecologic Oncology Division of the American Board of Obstetrics and Gynecology, and the Board of Governors of the American College of Surgeons. Dr. Karlan holds an Early Detection Professorship with the American Cancer Society.

Spotlight

Hear from Dr. Anil Sood, the Foundation’s Research Chairman, and Carol Brown, 2014 SGO Program Chair, about research of interest to women and the public presented at the 2014 SGO Annual Meeting on Women’s Cancer. Watch the video

Awareness

A new SGO Clinical Practice Statement states women diagnosed with epithelial ovarian, tubal, and peritoneal cancers should be considered for genetic counseling and testing, even in the absence of a family history.

Education

The next Gynecologic Cancer Survivors Course Friday, May 2, 2014 in Long Island, NY. For more information on courses, click here.